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Genetic studies of Wallerian degeneration have led to the identi-
fication of signaling molecules (e.g., dSarm/Sarm1, Axundead, and
Highwire) that function locally in axons to drive degeneration.
Here we identify a role for the Drosophila C2H2 zinc finger tran-
scription factor Pebbled [Peb, Ras-responsive element binding pro-
tein 1 (RREB1) in mammals] in axon death. Loss of Peb in
Drosophila glutamatergic sensory neurons results in either com-
plete preservation of severed axons, or an axon death phenotype
where axons fragment into large, continuous segments, rather
than completely disintegrate. Peb is expressed in developing and
mature sensory neurons, suggesting it is required to establish or
maintain their competence to undergo axon death. peb mutant
phenotypes can be rescued by human RREB1, and they exhibit
dominant genetic interactions with dsarm mutants, linking peb/
RREB1 to the axon death signaling cascade. Surprisingly, Peb is
only able to fully block axon death signaling in glutamatergic,
but not cholinergic sensory neurons, arguing for genetic diversity
in axon death signaling programs in different neuronal subtypes.
Our findings identify a transcription factor that regulates axon
death signaling, and peb mutant phenotypes of partial fragmen-
tation reveal a genetically accessible step in axon death signaling.
Wallerian degeneration | axons | axon death
Neurons are connected over long distances by their axons,which can extend over more than a meter in humans.
Maintenance of axon integrity is essential for sustained neural
circuit function because axon breakage can block nervous system
signal propagation. Axon loss is a hallmark of nervous system
injuries, such as traumatic brain injury and spinal cord injury
(1–3), is a unifying feature of neurodegenerative diseases (4),
and is strongly correlated with functional loss in patients (5).
Wallerian degeneration (WD; axotomy) serves as a useful
model to study basic aspects of axon biology, and to identify axon
death signaling molecules. Severed axons, after a defined latent
phase, undergo explosive fragmentation and are ultimately
cleared by surrounding phagocytes (6–8). The discovery of the
slow WD (WldS) mutant mouse, where severed distal axons sur-
vived for weeks after axotomy, radically changed our view of ax-
onal biology (9). The observed long-term survival of distal severed
axon fibers in WldS animals demonstrated that axon degeneration
is a controlled process, and that under some conditions, axons
could survive for weeks without a cell body (10–13). A growing
number of studies across several species support the notion that
the competence to undergo degeneration is likely a genetically
programmed event: in the rock lobster, distal severed axons have
been found to survive for a year after transection in vivo, and
remain capable of evoked release at neuromuscular junctions
(14); fragments of Aplysia axons can survive in vitro for extended
periods of time without degeneration (15); and in Caenorhabditis
elegans, most distal severed axons never degenerate (16). Despite
these surprising observations, to our knowledge, nothing is known
about transcriptional mechanisms that regulate the competence of
axons to degenerate.
In axons that do undergo WD, the execution of degeneration is
driven by axon death signaling molecules. Drosophila dSarm
(sterile α, ARM, and TIR domain protein) was the first endoge-
nous molecule shown to actively promote axon death (17).
Sarm1 functions in a conserved role in mammals (17, 18), where it
has been proposed to act as an NAD+ hydrolase that drives axonal
degeneration through promoting metabolic catastrophe (19, 20).
Drosophila dSarm is similarly capable of NAD+ hydrolysis (20),
but requires signaling downstream through the BTB/BACK do-
main molecule Axundead to execute axon death in vivo (21). The
E3 ubiquitin ligase Highwire/Phr1 also modulates axon death
signaling (22, 23) through a mechanism that appears to involve
regulating levels of the NAD+ biosynthetic molecule dNmnat/
Nmnat2 (22, 24). In both Drosophila and mammals, all neurons
tested thus far have been strongly protected by loss-of-function
mutations in dSarm/Sarm1 (17, 18, 25), which suggests that axon
death signaling molecules are engaged to drive destruction in a
wide array of, or perhaps all, neuronal subtypes.
In this study, we present the identification and characteriza-
tion of a role for Pebbled (Peb), a transcription factor, in axon
degeneration. peb mutants show two predominant axon death-
defective phenotypes: (i) severed distal axons are fully preserved
morphologically, or (ii) the axon shaft breaks into large frag-
ments (partially fragmented axons, PFAs) that fail to disintegrate
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further, lingering in the nervous system for weeks. The PFA
phenotype in peb mutants is not observed in control or axon
death mutants, and therefore defines a genetically accessible step
in axon death signaling. Surprisingly, while PFAs form in all
neurons, the ability of pebmutations to completely suppress axon
degeneration was only observed in glutamatergic neurons, and
not in cholinergic neurons, arguing that Peb functions to dif-
ferentially modulate competence to undergo axon degeneration
in distinct subsets of neurons.
Results
Isolation of a Mutant That Suppresses WD. To identify novel en-
dogenous regulators of WD, we performed an X chromosome-
based F2 forward genetic screen in glutamatergic sensory neu-
rons in the adult Drosophila wing using mosaic analysis using a
repressible cell marker (MARCM) (26). Flies were bred to
generate neuronal MARCM clones using the OK371-GAL4
driver, and axons were severed by surgical removal of the distal
half of the wing. Animals were aged for 7 d postaxotomy (dpa),
after which wings were dissected from the animal and axon death
was quantified and imaged in the proximal wing vein. Neurons
with cell bodies that were proximal to the injury site remained
healthy and uninjured, and served as internal controls, represented
by “cb” (cell body) in the upper right corner of each figure panel.
In control wings, injured axons typically undergo fragmenta-
tion by 12 h postaxotomy (hpa), degenerate fully by 24 hpa, and
are cleared by surrounding glia after 5 dpa (26). We screened
∼2,000 independent X-chromosome mutant stocks, and identi-
fied one, 345x, that exhibited suppression of WD (Fig. 1A).
While uninjured 345x mutant axons were similar in morphology
to control, 60% of injured axons in 345x mutants remained
partially or fully preserved at 7 dpa compared with 0% in wild-
type control: 22% of severed 345x mutant axons remained
morphologically intact, while 38% initiated fragmentation, but
were maintained as PFAs (Fig. 1B). We defined PFAs as GFP+
axon fragments that spanned the imaging field-of-view, and
were aligned linearly such that they appeared to represent the
remnants of a previously intact axon. We rarely observed PFAs
in control animals, and only early in the phase of axon de-
generation (Fig. 1D), but never in dsarm, axundead, or highwire
mutants (17, 21, 22). Therefore, 345x mutations result in an
axon death phenotype, apparently specific to the execution
phase of axonal destruction.
To distinguish PFAs from normal cellular debris produced by
degenerating axons, we measured the length of all GFP+ axonal
membrane debris from both control and 345x clones at 7 dpa.
The sparse debris in controls averaged 0.9 μm in length, while
345x mutant axons fragments averaged 3.0 μm, ranging in size
from 0.2 to 25.5 μm in length (Fig. 1C). Preserved intact axons
and PFAs persisted in 345x mutants over time, as both pheno-
types were observed out to 14 dpa (Fig. 1 D and E), although at
reduced levels.
While one portion of a severed axon in 345x mutants was fully
protected, it was plausible that PFAs might be generated at other
positions along the axon. To explore this possibility, we scored
axon morphological integrity with single-axon resolution along
the entire length of individual severed intact axons in the wing
vein of 345xmutants (Fig. 1 F andG). We found that when axons
were preserved in the proximal wing, 100% of those axons
remained morphologically intact along their entire length (Fig.
1H). We conclude that severed axons in 345x mutants fall into
one of three phenotypic categories: (i) they are morphologically
preserved along their entire length, (ii) they generate PFAs
along their entire length, or (iii) they degenerate and are cleared
normally.
Mitochondrial dysfunction is a hallmark in axon degeneration,
and is observed after axotomy and in neurodegenerative diseases
(27–29). In WldS-expressing axons, mitochondria persist after
axotomy long after mitochondria in control animals have been
destroyed (30). We therefore examined mitochondrial mor-
phology before and after axotomy in control and 345x mutant
clones. Using a GFP targeted to mitochondria, we found no
significant difference in the average mitochondria length in
uninjured neurons between control and 345x mutants (Fig. 1I).
Just before the explosive fragmentation stage of the distal axon,
at 8 h after injury, wild-type mitochondria began to decrease in
size, with an average length of 0.36 μm. At 8 hpa, mitochondria
of 345x mutants were significantly longer, with lengths averag-
ing 0.9 μm (Fig. 1I). However, when we looked at injured axons
24 h after injury, mitochondria in debris of control axons and
severed intact 345x mutant axons were indistinguishable (Fig.
1J). These data show that 345x mutant mitochondria exhibit a
normal, albeit delayed, morphological response to axon injury
within axon death-defective axons. This loss of mitochondria in
345x mutant axons that are morphologically intact is strikingly
different from dsarm-null mutant (Fig. 1 I and J) or WldS-expressing
severed axons (30). Surprisingly, 345x mutations are capable of pre-
serving axon integrity despite significant depletion of mitochondria.
The 345x Mutation Maps to the C2H2 Zinc Finger Transcription Factor
Pebbled/RREB1. 345x mutants were homozygous-lethal, suggesting
the mutation affected an essential gene. This observation was
supported by the fact that lethality associated with 345x cose-
gregated with the axon death phenotype during backcrossing
over five generations. To identify the gene affected by the 345x
mutation, we used genome-wide sequencing to identify muta-
tions in the backcrossed 345x mutant stock, and found only one
mutation that remained in 345x compared with the original
isolate, which was a mutation in the pebbled (peb) gene that
resulted in the loss of a splice donor site in exon 2 and generated
a premature stop codon (Fig. 2A). In a parallel set of experi-
ments, we screened a collection of X-chromosome deficiency
lines that had been recombined onto an FRT chromosome with
the MARCM approach. In total, these deficiencies removed
38.7% of X chromosome genes, and two nonoverlapping de-
ficiency lines led to a suppression of axon death (Fig. S1). The
first deficiency uncovered the E3 ubiquitin ligase Highwire, a
known axon death signaling molecule (22, 23). The second
overlapped with the genetic region to which we mapped 345x,
and included the peb gene.
Peb [Ras-responsive element binding protein 1 (RREB1) in
mammals] is a conserved transcription factor that contains 14
C2H2 zinc finger domains (31). In Drosophila embryos, Peb is
expressed in amnioserosa (AS), anterior and posterior midgut
(AM and PM, respectively), trachea, and in the peripheral ner-
vous system and imaginal discs during later stages (32–34). Loss
of Peb function leads to defects in embryonic germband re-
traction and dorsal closure of the embryonic epidermis, resulting
in lethality. Peb also plays important roles in axon guidance in
photoreceptor cells in the developing Drosophila visual system
(35, 36), but roles for Peb/RREB1 in axon death have not been
previously reported. We performed immunohistochemistry
(IHC) of early-stage embryos with α-Peb antibodies and con-
firmed that Peb was localized to the AS, and both the AM and
PM (Fig. 2B) (32). Consistent with our prediction that the 345x
mutations would lead to a loss of Peb protein product, we found
that embryos homozygous for 345x lacked α-Peb immunoreac-
tivity (Fig. 2B). IHC analyses in wing tissues during later stages of
development show Peb is detectable only within the nuclei of
developing and mature neurons and not present in the cytoplasm
of the cell body and axon (Fig. S3).
To confirm that the mutation of peb was responsible for the
axon death phenotype, we assayed axon death in adult wing
glutamatergic neurons with a second peb allele, pebE8 (37). We
found that pebE8 mutant clones phenocopied the 345x mutant
phenotype, although the phenotype was slightly weaker: in pebE8
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mutant MARCM clones 12% of severed axons remained mor-
phologically intact, and 21% formed PFAs (Fig. 2 C and D). We
next crossed a bacterial artificial chromosome (BAC) containing
the genomic copy of peb into 345x mutants, and found that
reintroduction of a wild-type copy of pebBAC into 345x mutants
completely rescued the axon death phenotypes (i.e., both axon
degeneration, the production of PFAs, and clearance of axonal
debris) to control levels (Fig. 2 E and F). Addition of pebBAC had
no effect on uninjured axons (Fig. S2). Furthermore, we found
that the pebBAC rescued the lethality of the 345x mutation. We
conclude that 345x is a mutation in the peb gene, and henceforth
refer to it as peb345x.
Human RREB1 Can Functionally Substitute for Pebbled. To explore
how Peb regulates axon death, we drove expression of cDNA
constructs encoding full-length Peb, truncated Peb containing
zinc fingers 1–8 or 10–14, and the human homolog, Ras-
responsive element binding protein 1, (Peb, Peb1−8, Peb10−14,
and hRREB1, respectively) in control and peb345x clones, and
quantified axon degeneration 7 dpa (Fig. 3A). Overexpression of
full-length Peb using the GAL4/UAS system (and driving ex-
pression with the OK371-GAL4 driver) was sufficient to com-
pletely rescue the blockade of axon degeneration observed in
peb345x clones: 100% of mutant axons initiated axon fragmenta-
tion (Fig. 3 B and C). Expression of the C-terminal zinc finger
domains 10–14 (in Peb10−14) was sufficient to rescue the axon
death defect in peb mutants. In contrast, expression of N-terminal
Peb1−8 failed to rescue the axon protective phenotype. This defines
the key domains essential for Peb function in prodegenerative
signaling, and provides additional support for a transcriptional role
for Peb, consistent with previous work demonstrating that
C-terminal domains are required for Peb to bind DNA in vitro
(31). Expression of hRREB1 was also sufficient to fully rescue the
blockade of axon degeneration (Fig. 3 B and C and Fig. S2), ar-
guing that Peb and hRREB1 exhibit similar properties with respect
to target gene regulation. However, while the initiation of axon
fragmentation was strongly rescued, 17% of the GFP+ injured
axons persisted as PFAs in peb345x background rescued with Peb.
This approximates the percentage of axons that form PFAs in
peb345x mutant clones expressing a UAS-LacZ control rescue
construct, and we observed PFAs in peb345x mutants rescued with
hRREB1 expression. Additionally, expression of either Peb or
hRREB1 in control animals led to the production of PFAs, which
are only ever rarely observed in the earliest phase of normal axon
degeneration (Fig. 3 B and C). These data suggest Peb expression
levels may need to be fine-tuned for proper rescue of execution of
axon death and destruction of PFAs, with too much or too little
Peb resulting in PFA formation.
Peb Loss Can Fully Preserve Severed Axons in Glutamatergic, but Not
Cholinergic Neurons. There are ∼250 sensory neurons in the
Drosophila wing that send axonal projections to the thoracic
ganglion in the CNS (38). Most cells fall into two subsets based
on neurotransmitter profiles: cholinergic (∼145 cells labeled by
ChAT-GAL4) and glutamatergic neurons (∼40 cell labeled by
vGlut-QF2 or OK371-GAL4) (Fig. 4 A and B) (26). Because the
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Fig. 1. Mutation 345x causes defective WD in vivo.
(A) Glutamatergic clones within the L1 anterior wing
vein were labeled with mCD8::GFP. Uninjured and
injured (7 dpa) are shown. (Scale bar, 10 μM.) Cell
bodies (cb) of uninjured clones within each wing were
counted and indicated in the upper right corner of
each panel. Mutant 345x exhibited two axon death-
defective phenotypes: either severed intact or PFAs.
(B) Quantification of peb mutant phenotype. PFAs
(gray) and severed intact axons (black). Daggers (†)
and asterisks (*) represent PFA and severed intact
significance, respectively (n > 30 wings). Two-way
ANOVA, error = SEM (**,††P < 0.01; ***,†††P < 0.001;
****,††††P < 0.0001). (C) Quantification of total con-
tinuous GFP+ axon debris length, 7 dpa. Unpaired
t test, error = SEM ****P < 0.0001. (D and E) Time-
course data for both controls and 345x mutants over
14 dpa (n > 30 wings). (F) Schematic of the adult wing
showing two imaging fields-of-view, proximal and
distal to the injury site. (G and H) Severed intact axons
were imaged and traced along the entirety of the
wing (individual images, outlined in grey, stitched
together, 63× magnification). Asterisks indicate cell
bodies of uninjured clones (n = 14 wings, 27 severed
intact axons). (I) Mitochondria (green) and gluta-
matergic neurons (red) of control and peb mutant
clones imaged and indicated time points. (Scale bar,
10 μM; Insets, 1 μM.) (J) Quantification of mitochon-
dria length at 8 hpa (control: n = 11 wings, 185 mitos.
peb: n = 13 wings, 241 mitos. dsarm: n = 11 wings,
158 mitos.), 1 dpa (control: n = 10 wings, 211 mitos.
peb: n = 16 wings 170 mitos. dsarm: n = 10 wings,
128 mitos), and 7 dpa (peb: n = 15 wings, 182 mitos.
dsarm: n = 12 wings, 209 measurements). One-way
ANOVA, Tukey’s multiple comparisons test, error
= SEM, ****P < 0.0001. ctrl, control; n/a, not appli-
cable; ns, not significant.
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peb345x mutation was identified and characterized in gluta-
matergic neurons, we wished to determine whether it also regu-
lated axon death signaling in cholinergic neurons. Approximately
23% of severed peb345x glutamatergic clones failed to undergo
axon degeneration at 7 dpa, and ∼40% of severed axons formed
PFAs (Fig. 4 C and D). When we assayed cholinergic peb345x
clones, we found a complete lack of protection from axon de-
generation: 100% of all neurons began fragmenting (Fig. 4 C and
D). Of severed axons, 19% form PFAs, indicating that peb also
regulates PFA formation at some level in cholinergic neurons
compared with control clones that underwent normal axon death
(Fig. S4). In axotomy assays with the pan-neuronal driver nSyb-
GAL4, we observed only 4% of severed mutant clones remaining
intact, and there was no change in PFAs compared with peb345x
glutamatergic clones. Control pan-neuronal clones had a normal
degenerative response to injury. Given that glutamatergic neurons
represent ∼20% of the nSyb-GAL4+ cells, we suspected the only
cells protected in this background by the peb345x mutation were
the glutamatergic neurons. Indeed, after screening many hundred
clones of injured axons where we simultaneously labeled cholin-
ergic neurons (with ChAT-GAL4) and glutamatergic neurons
(with vGlut-QF2), we only found a single severed, intact axon that
expressed ChAT-GAL4, and it was also positive for vGlut-QF2
and therefore also glutamatergic (Fig. 4E). The observation
that only glutamatergic neurons can be fully protected by peb345x
mutations, while PFAs appear with equal frequency in both cho-
linergic and glutamatergic neurons, further supports the notion
that the initiation (i.e., fragmentation) and execution (i.e., full
degradation) of axons are genetically separable and differentially
regulated by Peb levels. Moreover, ability of peb mutants to
completely block axon death is limited in the wing to gluta-
matergic sensory neurons.
peb Mutations Do Not Block dSarm-Induced Axon Death, Although
dsarmMutations Can Enhance pebMutant Phenotypes in Axon Death.
Activation of Sarm1 signaling potently drives axon death in
mammalian and Drosophila neurons (19). To determine whether
Peb acts downstream of dSarm, we crossed peb345xmutants into a
background expressing a gain-of-function version of dSarm
(dSarmΔARM) (21) and assayed for suppression of axon death.
Loss of Peb function was not sufficient to block dSarmΔARM-
induced axon death (Fig. 5 A and B), arguing that Peb does not
act genetically downstream of dSarm, and demonstrating that
constitutive activation of dSarm is sufficient to eliminate the
appearance of PFAs. We next sought to determine whether peb
mutants exhibited any dominant genetic interactions with com-
ponents of the axon death signaling cascade, including dsarm
(17), axundead (21), or highwire (22). We crossed loss-of-function
mutations of dsarm or axed into the peb345x background, and
found that loss of a single copy of dsarm was sufficient to double
the number of intact axons in peb345x animals, while loss of a
single copy of axed had no effect (Fig. 5C). Removal of one copy
of dsarm or axed in control clones had no effect on axon de-
generation (Fig. S4). In addition to the increase in fully pro-
tected axons, loss of one copy of dsarm also reduced the number
of PFAs in peb345xmutants (Fig. 5C). Reciprocally, we found that
overexpression of dSarm in a peb345x background led to a partial
suppression of the ability of peb345x to fully protect axons, and an
increase in the number of PFAs. Manipulation of Axed or Hiw
had no effect (Fig. 5D). Overexpression of dSarm, Axed, and
Hiw in control clones had no effect on axon degeneration (Fig.
S4). These data indicate the neuroprotective effects of peb345x
mutants are sensitive to dSarm levels.
Discussion
Distal axons separated from their cell bodies can survive in a
functionally competent state for days to weeks after axotomy in
multiple species (14, 21, 39). It therefore seems plausible that
some axons are programmed to degenerate while others are not.
In this study, we identify the transcription factor Pebbled (Peb)/
RREB1 as an essential modulator of axon death in Drosophila.
Through epistatic analysis, we can place peb upstream of dSarm
or in a separate, parallel pathway, which ultimately converges on
axon death. The simplest interpretation of our data is that Peb
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***,†††P < 0.001, ****,††††P < 0.0001). amg, anterior midgut; as, amnioserosa;
ctrl, control; pmg, posterior midgut.
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regulates axon death signaling in glutamatergic axons at the tran-
scriptional level. Human RREB1 can rescue axon death pheno-
types associated with loss of peb, arguing for strong conservation of
the binding properties of Peb and hRREB1, and implying that
RREB1 may play similar roles in axon biology in mammals.
Pebbled appears to identify a step in the axon death signaling
cascade. Loss of Pebbled function resulted in the appearance of
three axon phenotypes after injury: (i) full morphological pres-
ervation with a slightly delayed loss of mitochondria; (ii) the
generation of PFAs that linger in the nervous system for weeks,
but which also lose mitochondria after a short delay; or
(iii) apparently normal axon death signaling and clearance. The
cell biology of axon preservation in peb mutants is unique, and
implies that peb mutants identify a genetically accessible step in
axon death signaling. PFAs have not been observed in other axon
death mutants (i.e., dsarm, hiw, or axed), as these mutants all fully
block axon degeneration after axotomy (17, 21, 23). Un-
derstanding the nature of PFA production compared with normal
axon degeneration is an important goal for future study. In the
case of dsarm mutants, in addition to the axon shaft maintaining
complete integrity, mitochondria also appeared well-preserved.
That was not the case in peb mutants, where mitochondria
degenerated after only a short delay, and preserved axons were
severely depleted of mitochondria for the duration of their ex-
tended survival. Interestingly, the phenotype of individual peb
mutant axons is consistent along the entirety of the axon shaft: we
never observed an axon that generated PFAs in one portion, but
was fully protected elsewhere. Unraveling the molecular basis of
this all-or-none type of phenotypic expression is of great interest
for the future. Finally, while some PFAs are observed in control
animals immediately after the initiation of axon fragmentation,
they quickly undergo explosive degeneration and are cleared.
From these data, we conclude that Peb functions both at the initial
phase of axon breakage into smaller fragments, and subsequently
during the phase of explosive degeneration.
To date all known axon death signaling molecules—dSarm,
Hiw, and Axed—have been proposed to function locally in the
axon to drive destruction, and their neuroprotective effects ex-
tend to both glutamatergic and cholinergic neurons (17, 21, 22).
Based on its expression in the nuclei of wing sensory neuron
precursors and mature neurons, and the fact it is a C2H2 zinc
finger transcription factor, we propose that Peb functions at the
transcriptional level to help establish and maintain competence to
undergo axon degeneration. While Peb appears to be expressed
broadly in wing sensory neurons, surprisingly, the ability of peb
mutants to fully block axon fragmentation is restricted to gluta-
matergic neurons. How Peb selectively protects glutamatergic
axons is unclear, but could modify axonal phenotypes through the
JNK signaling cascade. During embryogenesis, in AS peb mutants
show increased levels of AP-1 transcriptional activity downstream
of the JNK signaling cascade (40), which in turn inhibits
cytoskeletal rearrangements that allow for cell migration (32, 40).
We have found a lack of evidence to support a role for JNK
signaling in axon death (17, 21), but some data support a neuro-
protective role for this pathway by controlling baseline levels of
Nmnat (41). Peb has also been shown to negatively regulate nervy,
the Drosophila homolog of mammalian MTG8 proto-oncogene
(31); however, we observed no alterations in axon death when
we overexpressed nervy in glutamatergic neurons.
The nuclear localization requirement of the carboxy terminal
DNA binding zinc finger domains of Peb for rescue suggests that
Peb is regulating injury-induced axon degeneration at the tran-
scriptional level. We attempted to identify direct transcriptional
targets of Peb by expressing a tagged version of Peb in the
Drosophila embryonic cell line, GM2, and performing ChIP with
antibodies specific to tagged Peb and subsequent deep se-
quencing (ChIP-seq). This approach successfully identified the
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one known target for Peb, the transcriptional regulator Nervy,
whose overexpression did not block axon death, and several
potential Peb targets (Table S1). We did not find evidence for
direct binding of Peb to regions containing known axon death
signaling genes (i.e., dsarm, axed, or hiw). This could indicate
that Peb does not directly modulate axon death genes in vivo to
exert its effects, although it remains unclear how similar Peb
transcriptional activity in GM2 cells might be compared with
neurons. Finally, it remains unclear why dsarm, but not axed
mutations, modify peb mutant phenotypes, given that Axed sig-
nals downstream of dSarm in axon death. A deeper under-
standing of the molecular basis of axon degeneration, and the
nature of PFAs, will likely be required to answer this question.
Our analysis of peb mutant phenotypes reveals features of the
cell biology of axon death. Our discovery of PFAs in peb mutants
implies that axon degeneration can be genetically dissected
into distinct activation and execution phases, and we propose
that PFAs represent activation, but failure to execute axon
death. We found that either increased or decreased Peb levels
could lead to the production of PFAs, arguing that fine-tuning of
Peb levels is essential for appropriate execution of axon death.
Furthermore, Peb modulation of PFA production is not limited
to glutamatergic neurons, since we found PFAs in cholinergic
neurons under both loss- and gain-of-function Peb conditions.
Interestingly, Peb allows us to genetically separate mitochondrial
loss from axon degeneration. We observed mitochondrial degen-
eration even in fully protected peb mutant axons, indicating that
mitochondrial destruction must occur through a Peb-independent
signaling pathway.
Methods
See SI Methods for more information and detailed descriptions of animal
genotypes, EMS mutagenesis, transgenic constructs, the wing axotomy as-
say, subsequent wing microscopy, IHC procedures, antibodies used, cell cul-
ture techniques, ChIP methods, and deep sequencing analyses.
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